▶1:57This interface is currently displayed in English. Full translation is in preparation.
Changemakers Award 3 - AerlyPap: Youth-Led Innovation for Public Health (Peru)
Journalists and Writers Foundation JWF8th Annual Pioneers in SDGs 2026 Awards 4 November 2026, Wednesday - 10:00 AM EST Changemakers Award 3 AerlyPap: Youth-Led Innovation for Public Health (Peru) Cristiano Gerardo Sebastian Gonzales Castro, Co-founder, AerlyPap AerlyPap is a Peruvian project developing affordable CPAP systems for patients facing financial or geographic barriers. Its device combines a locally made airflow unit, a personalized 3D-printed mask using recycled PET and medical-grade silicone, and an app that controls airflow and records usage. Costing about $120—76% less than commercial alternatives—it has been tested Read moreShow less
8th Annual Pioneers in SDGs 2026 Awards
4 November 2026, Wednesday - 10:00 AM EST
www.unga-conference.org
Changemakers Award 3
AerlyPap: Youth-Led Innovation for Public Health (Peru)
Cristiano Gerardo Sebastian Gonzales Castro, Co-founder, AerlyPap
AerlyPap is a Peruvian project developing affordable CPAP systems for patients facing financial or geographic barriers. Its device combines a locally made airflow unit, a personalized 3D-printed mask using recycled PET and medical-grade silicone, and an app that controls airflow and records usage. Costing about $120—76% less than commercial alternatives—it has been tested with 50 patients. The team aims to provide free systems to low-income patients and expand across Peru.
4 November 2026, Wednesday - 10:00 AM EST
www.unga-conference.org
Changemakers Award 3
AerlyPap: Youth-Led Innovation for Public Health (Peru)
Cristiano Gerardo Sebastian Gonzales Castro, Co-founder, AerlyPap
AerlyPap is a Peruvian project developing affordable CPAP systems for patients facing financial or geographic barriers. Its device combines a locally made airflow unit, a personalized 3D-printed mask using recycled PET and medical-grade silicone, and an app that controls airflow and records usage. Costing about $120—76% less than commercial alternatives—it has been tested with 50 patients. The team aims to provide free systems to low-income patients and expand across Peru.
